Navigation Links
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
Date:5/7/2009

and announced positive results from both of its AZ-004 Phase 3 clinical trials, and is projecting a New Drug Application submission in early 2010.

The Company has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and it has advanced AZ-104 (Staccato loxapine) into Phase 2b testing. Both product candidates are being developed for the acute treatment of migraine headache. AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to two fiscal quarters, and to provide, update or reconfirm its guidance only by issuing a press release or filing updated guidance with the SEC in a publicly accessible document. Clinical guidance is as of May 7, 2009 and financial guidance relating to the Company's current cash, cash equivalents and investments is as of March 31, 2009.

This press release and anticipated conference call include forward-looking statements regarding the development of the Company's product candidates, projected clinical trial enrollment and data reporting timelines, and safety of the Company's products and technologies. Any statement describing a product candidate or Alexza's goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
2. Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
3. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
4. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
7. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
8. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
9. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
10. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
11. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Tissue ... the regenerative medical devices company, announces that it ... wound care market as Tissue Regenix Wound Care ... Medicare administrator, First Coast Service Options Inc. ("First ... , Puerto Rico and ...
(Date:7/29/2015)... , July 30, 2015 ... Guidance   for ... Core Earnings and Core ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
(Date:7/29/2015)... , July 29, 2015 Insulet Corporation (NASDAQ: ... technology with its OmniPod ® Insulin Management System, ... ended June 30, 2015. The Company also announced that ... quarter financial results and conference call from Thursday, July ... Second Quarter Revenue Highlights: , ...
Breaking Medicine Technology:Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5
... and Physician,Reports that Children with Autism Spectrum ... Fever, BALTIMORE, Dec. 3 Over ... observed that the behaviors of children with,autism ... rather,dramatically, during a fever. Longer concentration spans, ...
... World AIDS,Day 2007, CHF International is honoring the struggle ... HIV/AIDS, but calls for greater,international support of grassroots, community-based ... decades, international assistance has made a marked,impact in helping ... means that more people are able to treat their ...
Cached Medicine Technology:Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 2Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 3Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 4On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS 2On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS 3
(Date:7/30/2015)... Ind. (PRWEB) , ... July 30, 2015 , ... ... communication system now offers tracking and reporting for reimbursement from the Centers for ... chronic care. , “Right now, providers are experimenting with manual data capture or, ...
(Date:7/30/2015)... ... ... Addictions Training Institute has announced the launch of a fully online ... Counselors. , "We are thrilled to be launching Addictions Training Institute,” said Ron Black, ... Drug Counselors nationwide. We are excited to be helping fill this need and ...
(Date:7/29/2015)... ... July 30, 2015 , ... Drs. Hamstead are very excited to ... massage therapy to the offerings in the clinic; massage therapy works very well alongside ... therapist Crystal Gaines has joined AlignLife of Simpsonville to work alongside the doctors. Many ...
(Date:7/29/2015)... ... ... According to data released today by the Centers for Medicare & Medicaid Services, ... $32.50, a figure far lower than was originally projected, the Pharmaceutical Care Management Association ... in American health care. By offering an abundance of competing choices in each region ...
(Date:7/29/2015)... Lake Mary, FL (PRWEB) , ... July 29, 2015 , ... ... of Healthcare Providers and Systems (CAHPS) for PQRS Survey. , The CAHPS for ... setting. In 2015, practices of 100 or more eligible providers must participate or they ...
Breaking Medicine News(10 mins):Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3
... for the first time, identified Apolipoprotein E (APOE), ... disease in adults, can also increase the likelihood ... ,This is the first identification of a ... of the study, published in the February issue ...
... out by non-profit National Institute of Cancer Research delving into ... treatment of cancer has come out with significant findings. ... show that a low fat diet can decrease the recurrence ... receptor(ER)- negative breast cancer. ,The study was carried ...
... that are cloned will not bear any labels to signify ... consumption, there is no necessary to indicate its source. // ... U.S. Government on consumption of food from cloned animals is ... will evaluate and consider the public’s comments on this issue ...
... without taking a break has helped a doctor here to ... technique of single hole surgery. ,Doctor Ajay Prakash ... around 10 p.m. Thursday night and continued surgeries without a ... and five appendixes, with his surgery technique, which he describes ...
... this number to your need-to-know file: your body mass index.// ... cholesterol level, your body mass index (BMI) has an impact ... type 2 diabetes and some cancers. With a lower BMI, ... of blood sugar and cholesterol. ,Mayo Clinic’s ...
... benefits of mammogram screenings because the results are not ... Public Health researchers in the March issue of American ... reduce death and disability from breast cancer, the second ... current guidelines recommend routine mammography screening for women aged ...
Cached Medicine News:Health News:Newborns' Cerebral Palsy Risk Increased By Alzheimer's Gene 2Health News:Body Mass Index: Do You Know Yours? 2Health News:Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women 2
Online Unity Interlaboratory QC Data Management...
The ACCU-CHEK Spirit insulin pump system offers frequent and precise delivery of the basal rate and rapid infusion of the bolus. The ACCU-CHEK Spirit pump is safe, reliable and easy to program....
The Kowa Non-Contact Tonometer KT-800 comes with a one year parts and labor warranty....
... acne, XtremeClear, powered by LHE, provides ... multi-application platform. A powerful tool in ... fast, providing noticeable results usually within ... in each of its applications, XtremeClear ...
Medicine Products: